Ethical considerations in CMS's coverage with evidence development.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 22137000.
- Also identified by DOI 10.1016/j.jacr.2011.08.011.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
This paper reviews the CMS coverage with evidence development policy, its manner of implementation, and key ethical issues raised by the policy. The author describes ethical considerations and issues associated with the process of coverage with evidence development for generating evidence for novel or emerging technologies.
Medical subject headings
- Centers for Medicare and Medicaid Services, U.S.
- Evidence-Based Medicine
- Health Care Rationing
- Public Policy
- Resource Allocation